Literature DB >> 20164250

Interactive changes between macrophages and adipocytes.

Linglin Xie1, M Teresa Ortega, Silvia Mora, Stephen K Chapes.   

Abstract

Obesity is associated with a proinflammatory state, with macrophage infiltration into adipose tissue. We tested the hypothesis that communication between macrophages and adipocytes affects insulin resistance by disrupting insulin-stimulated glucose transport, adipocyte differentiation, and macrophage function. To test this hypothesis, we cocultured 3T3-L1 adipocytes with C2D macrophages or primary peritoneal mouse macrophages and examined the impacts of macrophages and adipocytes on each other. Adipocytes and preadipocytes did not affect C2D macrophage TNF-alpha, IL-6, or IL-1beta transcript concentrations relative to those obtained when C2D macrophages were incubated alone. However, preadipocytes and adipocytes increased PEC-C2D macrophage IL-6 transcript levels, while preadipocytes inhibited IL-1beta transcript levels compared to those obtained when PEC-C2D macrophages were incubated in medium alone. We found that adipocyte coculture increased macrophage consumption of tumor necrosis factor alpha (TNF-alpha), interleukin 1beta (IL-1beta), and, in some cases, IL-6. C2D macrophages increasingly downregulated GLUT4 transcript levels in differentiated adipocytes. Recombinant TNF-alpha, IL-1beta, and IL-6 also downregulated GLUT4 transcript levels relative to those for the control. However, only IL-6 was inhibitory at concentrations detected in macrophage-adipocyte cocultures. IL-6 and TNF-alpha, but not IL-1beta, inhibited Akt phosphorylation within 15 min of insulin stimulation, but only IL-6 was inhibitory 30 min after stimulation. Lastly, we found that adipocyte differentiation was inhibited by macrophages or by recombinant TNF-alpha, IL-6, and IL-1beta, with IL-6 having the most impact. These data suggest that the interaction between macrophages and adipocytes is a complex process, and they support the hypothesis that the macrophage-adipocyte interaction affects insulin resistance by disrupting insulin-stimulated glucose transport, adipocyte differentiation, and macrophage function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164250      PMCID: PMC2849320          DOI: 10.1128/CVI.00494-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  46 in total

1.  The world health report 2002 - reducing risks, promoting healthy life.

Authors:  J J Guilbert
Journal:  Educ Health (Abingdon)       Date:  2003-07

2.  Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade.

Authors:  Miyuki Suzawa; Ichiro Takada; Junn Yanagisawa; Fumiaki Ohtake; Satoko Ogawa; Toshimasa Yamauchi; Takashi Kadowaki; Yasuhiro Takeuchi; Hiroshi Shibuya; Yukiko Gotoh; Kunihiro Matsumoto; Shigeaki Kato
Journal:  Nat Cell Biol       Date:  2003-03       Impact factor: 28.824

3.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

Authors:  Joachim Spranger; Anja Kroke; Matthias Möhlig; Kurt Hoffmann; Manuela M Bergmann; Michael Ristow; Heiner Boeing; Andreas F H Pfeiffer
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

4.  Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory.

Authors:  Hong Ruan; Nir Hacohen; Todd R Golub; Luk Van Parijs; Harvey F Lodish
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

5.  Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

Authors:  Claire Lagathu; Jean-Philippe Bastard; Martine Auclair; Mustapha Maachi; Jacqueline Capeau; Martine Caron
Journal:  Biochem Biophys Res Commun       Date:  2003-11-14       Impact factor: 3.575

Review 6.  Insulin sensitivity: modulation by nutrients and inflammation.

Authors:  Simon Schenk; Maziyar Saberi; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

7.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

Authors:  Haiyan Xu; Glenn T Barnes; Qing Yang; Guo Tan; Daseng Yang; Chieh J Chou; Jason Sole; Andrew Nichols; Jeffrey S Ross; Louis A Tartaglia; Hong Chen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 9.  Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi
Journal:  Kidney Int Suppl       Date:  2003-05       Impact factor: 10.545

10.  Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects.

Authors:  Victoria Rotter; Ivan Nagaev; Ulf Smith
Journal:  J Biol Chem       Date:  2003-09-02       Impact factor: 5.157

View more
  31 in total

1.  Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes.

Authors:  Y-S Lee; M-S Park; J-S Choung; S-S Kim; H-H Oh; C-S Choi; S-Y Ha; Y Kang; Y Kim; H-S Jun
Journal:  Diabetologia       Date:  2012-06-22       Impact factor: 10.122

2.  Evaluation of macrophage plasticity in brown and white adipose tissue.

Authors:  M Teresa Ortega; Linglin Xie; Silvia Mora; Stephen K Chapes
Journal:  Cell Immunol       Date:  2011-06-23       Impact factor: 4.868

Review 3.  Neurogenic obesity and systemic inflammation following spinal cord injury: A review.

Authors:  Gary J Farkas; David R Gater
Journal:  J Spinal Cord Med       Date:  2017-07-30       Impact factor: 1.985

Review 4.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

5.  Depletion of dendritic cells in perivascular adipose tissue improves arterial relaxation responses in type 2 diabetic mice.

Authors:  Tianyi Qiu; Min Li; Miles A Tanner; Yan Yang; James R Sowers; Ronald J Korthuis; Michael A Hill
Journal:  Metabolism       Date:  2018-03-09       Impact factor: 8.694

6.  Pro-atherogenic and pro-oxidant crosstalk between adipocytes and macrophages.

Authors:  Lili Nimri; Claudia Grajeda-Iglesias; Nina Volkova; Michael Aviram
Journal:  Eur J Nutr       Date:  2018-05-26       Impact factor: 5.614

7.  Exposure to an organometal compound stimulates adipokine and cytokine expression in white adipose tissue.

Authors:  Palaniyandi Ravanan; G Jean Harry; Rana Awada; Laurence Hoareau; Frank Tallet; Régis Roche; Christian Lefebvre d'Hellencourt
Journal:  Cytokine       Date:  2010-12-30       Impact factor: 3.861

Review 8.  Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review.

Authors:  Faezeh Vahdati Hassani; Kobra Shirani; Hossein Hosseinzadeh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-13       Impact factor: 3.000

9.  Establishment and characterization of DB-1: a leptin receptor-deficient murine macrophage cell line.

Authors:  Lea H Dib; M Teresa Ortega; Tonatiuh Melgarejo; Stephen K Chapes
Journal:  Cytotechnology       Date:  2015-01-20       Impact factor: 2.058

10.  Mitigation of isolation-associated adipocyte interleukin-6 secretion following rapid dissociation of adipose tissue.

Authors:  Airlia C S Thompson; Martha Nuñez; Ryan Davidson; Teresa Horm; Karina Schnittker; Madeline V Hart; Allen M Suarez; Tsu-Shuen Tsao
Journal:  J Lipid Res       Date:  2012-08-21       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.